Ingredient guide · Ingredient reference

Vitamin B3 for glaucoma: there is no established self-treatment dose

Do not choose a high-dose vitamin B3 regimen for glaucoma from a supplement label. Nicotinamide is under investigation, and specialist guidance warns about liver injury. A trial amount is not an approved treatment dose or a substitute for pressure-lowering eye care.

Read the evidence ↓

Supplement Science Insights Editorial Team

Published September 23, 2026

The specialist warning includes a dose boundary

The author of the 2025 AGS/AAO position statement advises against nicotinamide at 3 grams per day or more outside monitored clinical trials. Even lower amounts require coordination with the treating physician and liver-function monitoring; below 3 grams does not mean established safety. [1]

B3 products are not interchangeable

Nicotinamide and nicotinic acid are different forms within the B3 category. Do not substitute a niacin cholesterol product for a nicotinamide research preparation. Ordinary nutritional requirements are also not the same question as a proposed pharmacological regimen for an eye disease. [2][1]

Keep established glaucoma treatment in place

NEI describes medicines, usually eye drops, laser treatment and surgery as treatment options. Glaucoma may progress without noticeable early symptoms. Supplement use does not replace scheduled examinations or the treatment selected to protect vision. [3]

Liver history and symptoms matter

The position-statement author advises against potential nicotinamide therapy in people with current or past liver dysfunction. Nausea, vomiting or yellowing of skin or eyes during use should be reported promptly, with emergency evaluation when severe. [1]

Convert the units without converting them into advice

Imagine a research description mentions 3 grams and a bottle supplies 500 mg per capsule. Three grams equals 3,000 mg, or six such capsules. That calculation explains why research exposure can be substantial; it is not an instruction to take six capsules. [1]

Hypothetical example — distinguish a comfort measure from treatment
SituationResponse
3 g equals 3,000 mgResearch boundary, not a home regimen
Lower than 3 gStill needs clinical oversight
B3 product switchForms are not interchangeable
Vitamin B3 for glaucoma: there is no established self-treatment dose — original article outline diagram
Original editorial diagram of this article’s sections; no product photograph or clinical finding is depicted.

Sources for this article

  1. Investigating Nicotinamide and Pyruvate for Glaucoma Neuroprotection
    Source consulted: 2026-09-20. This is a reference resource, not a claim that we conducted the studies or tested a product.
  2. Niacin - Health Professional Fact Sheet
    Source consulted: 2026-09-20. This is a reference resource, not a claim that we conducted the studies or tested a product.
  3. Glaucoma
    Source consulted: 2026-09-20. This is a reference resource, not a claim that we conducted the studies or tested a product.